FIELD: medicine.
SUBSTANCE: inventions group relates to medicine, namely to ophthalmology and pharmacology, and is intended for preparing an eye drop solution for protecting the eye from UV rays of group A/B. The solution of eye drops to protect the eye from UV rays of group A/B (UV group A - 315-400 nm; UV group B - 315-280 nm) contains liposomes built using non-hydrogenated phospholipids containing linseed oil; vitamin A in the form of palmitate; vitamin E in the form of TPGS; as well as vitamin B12 and pycnogenols in the aqueous phase. A method for preparing said solution of eye drops is also presented.
EFFECT: use of the inventions group makes it possible to obtain a solution of eye drops having an increased antioxidant activity, as well as an increased protective effect.
7 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
EYE DROPS BASED ON COMPOSITION OF PHARMACEUTICALLY ACCEPTABLE ADDITIVE ACID SALTS AND METHYLETHYL PYRIDONOL AND TAURINE CONTAINING COMPOSITION OF GROUP B VITAMINS | 2013 |
|
RU2533276C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING CYCLOSPORINE | 2006 |
|
RU2421209C2 |
METHOD OF PRODUCING LIPOSOMAL COSMETIC SERUM IN DRY LYOPHILIZED FORM FOR FACE, NECK AND CLEAVAGE SKIN CARE | 2023 |
|
RU2825130C1 |
COMPOSITION FOR TAKING CARE OF FACIAL SKIN AND EYELIDS | 2002 |
|
RU2218907C1 |
STERILE DROP-LIQUID OPHTHALMOLOGICAL GEL-PREPARATION AND METHOD OF ITS PRODUCTION | 1996 |
|
RU2172169C2 |
BIS-NAPHTHAZARIN BASED AGENT AND METHOD FOR PRODUCTION THEREOF | 2016 |
|
RU2669374C2 |
PHARMACEUTICAL COMPOSITION FOR INTEGRATED TREATMENT OF OCULAR SURFACE DISEASES IN PATIENTS SUFFERING PRIMARY OPEN-ANGLE GLAUCOMA | 2011 |
|
RU2460517C1 |
COMPOSITION FOR INTEGRATED TREATMENT OF PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AND OCULAR SURFACE DISEASES | 2013 |
|
RU2517033C1 |
STERILE MULTI-PHASE DROP EYE MEDICATION | 2006 |
|
RU2414887C2 |
Authors
Dates
2022-10-06—Published
2019-10-24—Filed